Trademark Search in Canada

KALVISTA

View On IC.GC.CA

ADVERTISED

on 19 Feb 2025

Last Applicant/ Owned by

Kalvista Pharmaceuticals Limited

Porton Science Park, Bybrook Road,Porton DownSalisbury, Wiltshire SP4 0BF

Serial Number

2213217 filed on 20^th Jul 2022

Correspondent Address

MAY M.M. CHENG

(Dipchand LLP)401 Bay Street, Suite 2100Toronto

ONTARIO

M5H2Y4

KALVISTA

Trademark usage description

pharmaceutical preparations for the treatment of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of diabetic macular Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of diabetic macular edema; pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of blood diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of blood plasma kallikrein and blood factor XIIa mediated diseases and disorders.

Classification kind code

Class [010]
Surgical instruments and apparatus for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, blood diseases and disorders mediated by the contact activation system, and blood plasma kallikrein and factor XIIa mediated diseases and disorders; drug delivery devices for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders, namely, drug delivery catheters, implantable drug delivery device, implantable drug delivery pumps, implantable ocular drug delivery devices, implantable subcutaneous drug delivery devices; injection syringes.

Classification kind code

Class [042]
Drug discovery services relating to ophthalmic diseases and disorders; drug discovery services relating to diabetic macular edema; drug discovery services relating to angioedema; drug discovery services relating to hereditary angioedema; drug discovery services relating to diseases and disorders mediated by the contact activation system; drug discovery services relating to plasma kallikrein and factor XIIa mediated diseases and disorders.

Classification kind code

Class [044]
Medical services in the field of treatment of ophthalmic diseases and disorders; providing medical information in the treatment of ophthalmic diseases and disorders; medical services in the field of treatment of diabetic macular edema; providing medical information in the treatment of diabetic macular edema; medical services in the field of treatment of angioedema; providing medical information in the treatment of angioedema; medical services in the field of treatment of hereditary angioedema; providing medical information in the treatment of hereditary angioedema; medical services in the field of treatment of blood diseases and disorders mediated by the contact activation system; providing medical information in the treatment of blood diseases and disorders mediated by the contact activation system; medical services in the field of treatment of blood plasma kallikrein and blood factor XIIa mediated diseases and disorders; providing medical information in the treatment of blood plasma kallikrein and blood factor XIIa mediated diseases and disorders.

Classification kind code

Mark Details

Serial Number

2213217

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 12^th Jan 2024	Search Recorded
Submitted for opposition 20 on 12^th Jan 2024	Examiner's First Report
Submitted for opposition 256 on 31^st Jul 2023	Notification of Possible Opposition Sent
Submitted for opposition 48 on 12^th Apr 2023	Agent Changed
Submitted for opposition 48 on 17^th Jan 2023	Agent Changed
Submitted for opposition 1 on 1^st Oct 2022	Created
Submitted for opposition 31 on 1^st Oct 2022	Formalized
Submitted for opposition 257 on 29^th Sept 2022	Designation Notification - Madrid Protocol
Submitted for opposition 30 on 20^th Jul 2022	Filed
Submitted for opposition 228 on 20^th Jul 2022	International Registration